COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 962: Articles 9611-9620  | Next

A structural dynamic explanation for observed escape of SARS-CoV-2 BA.2 variant mutation S371L/F
Miller, N. L., Clark, T., Raman, R., Sasisekharan, R.
10.1101/2022.02.25.481957 — Posted: 2022-02-26
Transcriptomic landscapes of SARS-CoV-2-infected and bystander lung cells reveal a selective upregulation of NF-κB-dependent coding and non-coding proviral transcripts
Szachnowski, U., Bhargava, A., Chazal, M., Foretek, D., Aicher, S.-M., Pipoli da Fonseca, J., Jeannin, P., Beauclair, G., Monot, M., Morillon, A., Jouvenet, N.
10.1101/2022.02.25.481978 — Posted: 2022-02-26
Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution
Starr, T. N., Greaney, A. J., Hannon, W. W., Loes, A. N., Hauser, K., Dillen, J. R., Ferri, E., Ghez Farrell, A., Dadonaite, B., McCallum, M., Matreyek, K. A., Corti, D., Veesler, D., Snell, G., Bloom, J. D.
10.1101/2022.02.24.481899 — Posted: 2022-02-26
IgG1 responses following SARS-CoV-2 infection are polyclonal and highly personalized, whereby each donor and each clone displays a distinct pattern of cross-reactivity against SARS-CoV-2 variants
van Rijswijck, D. M. H., Bondt, A., Hoek, M., van der Straten, K., Caniels, T. G., Poniman, M., Eggink, D., Reusken, C. B. E. M., de Bree, G. J., Sanders, R. W., van Gils, M., Heck, A. J. R.
10.1101/2022.02.24.481778 — Posted: 2022-02-26
Breakthrough SARS-CoV-2 Infection Outcomes in Vaccinated Patients with Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study
Ge, J., Digitale, J. C., Pletcher, M. J., Lai, J. C., N3C Consortium
10.1101/2022.02.25.22271490 — Posted: 2022-02-26
Reassessment of persistent symptoms, self-reported COVID-19 infection and SARS-CoV-2 serology in the SAPRIS-SERO cohort: identifying possible sub-syndromes of Long Covid.
Spiers, N.
10.1101/2022.02.25.22271499 — Posted: 2022-02-26
Duration of Protection Against SARS-CoV-2 Reinfection and Associated Risk of Reinfection Assessed with Real-World Data
Reynolds, S. L., Kaufman, H. W., Meyer, W. A., Bush, C., Cohen, O., Cronin, K., Kabelac, C., Leonard, S., Anderson, S., Petkov, V., Lowy, D., Sharpless, N., Penberthy, L.
10.1101/2022.02.25.22271515 — Posted: 2022-02-26
Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a Scoping Review
Carvalho, A. S., Brito Fernandes, O., de Lange, M., Lingsma, H., Klazinga, N., Kringos, D.
10.1101/2022.02.23.22271303 — Posted: 2022-02-26
Late-Ensemble of Convolutional Neural Networks with Test Time Augmentation for Chest XR COVID-19 Detection
Qayyum, A., Razzak, I., Mazher, M., Puig, D.
10.1101/2022.02.25.22271520 — Posted: 2022-02-26
Dictionary learning for integrative, multimodal, and scalable single-cell analysis
Hao, Y., Stuart, T., Kowalski, M., Choudhary, S., Hoffman, P., Hartman, A., Srivastava, A., Molla, G., Madad, S., Fernandez-Granda, C., Satija, R.
10.1101/2022.02.24.481684 — Posted: 2022-02-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).